13F HOLDINGS REPORT
Ghost Tree Capital, LLC
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001420506-23-002080
Total Value
$304.1M
Positions
70
Other Managers
0
Confidential Omitted
No
Holdings (70)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | SPDR SER TR | 78464A870 | 300,000 | $21.9M | 7.20% |
| 2 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 330,000 | $18.8M | 6.19% |
| 3 | SAREPTA THERAPEUTICS INC | SRPT | 150,000 | $18.2M | 5.98% |
| 4 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 250,000 | $14.3M | 4.69% |
| 5 | AKERO THERAPEUTICS INC | 00973Y108 | 250,000 | $12.6M | 4.16% |
| 6 | KRYSTAL BIOTECH INC | KRYS | 80,000 | $9.3M | 3.05% |
| 7 | MADRIGAL PHARMACEUTICALS INC | MDGL | 57,500 | $8.4M | 2.76% |
| 8 | TG THERAPEUTICS INC | TGTX | 1,000,000 | $8.4M | 2.75% |
| 9 | ASCENDIS PHARMA A/S | ASND | 85,000 | $8.0M | 2.62% |
| 10 | AXSOME THERAPEUTICS INC | AXSM | 110,000 | $7.7M | 2.53% |
| 11 | ALPINE IMMUNE SCIENCES INC | 02083G100 | 664,132 | $7.6M | 2.50% |
| 12 | VAXCYTE INC | PCVX | 140,000 | $7.1M | 2.35% |
| 13 | TARSUS PHARMACEUTICALS INC | TARS | 400,000 | $7.1M | 2.34% |
| 14 | PROTAGONIST THERAPEUTICS INC | PTGX | 400,000 | $6.7M | 2.19% |
| 15 | COGENT BIOSCIENCES INC | COGT | 650,000 | $6.3M | 2.08% |
| 16 | ROCKET PHARMACEUTICALS INC | RCKTW | 295,000 | $6.0M | 1.99% |
| 17 | AMBRX BIOPHARMA INC | 02290A102 | 525,000 | $6.0M | 1.99% |
| 18 | AKERO THERAPEUTICS INC | 00973Y108 | 115,000 | $5.8M | 1.91% |
| 19 | IMMUNOVANT INC | IMVT | 130,000 | $5.0M | 1.64% |
| 20 | SAREPTA THERAPEUTICS INC | SRPT | 40,000 | $4.8M | 1.59% |
| 21 | APELLIS PHARMACEUTICALS INC | APLS | 120,000 | $4.6M | 1.50% |
| 22 | SYNDAX PHARMACEUTICALS INC | SNDX | 300,000 | $4.4M | 1.43% |
| 23 | PMV PHARMACEUTICALS INC | PMVP | 705,881 | $4.3M | 1.43% |
| 24 | REPLIMUNE GROUP INC | REPL | 250,000 | $4.3M | 1.41% |
| 25 | VIRIDIAN THERAPEUTICS INC | VRDN | 275,000 | $4.2M | 1.39% |
| 26 | TAYSHA GENE THERAPIES INC | TSHA | 1,325,000 | $4.2M | 1.38% |
| 27 | DECIPHERA PHARMACEUTICALS IN | 24344T101 | 325,000 | $4.1M | 1.36% |
| 28 | PHATHOM PHARMACEUTICALS INC | PHAT | 395,000 | $4.1M | 1.35% |
| 29 | REVANCE THERAPEUTICS INC | 761330109 | 350,000 | $4.0M | 1.32% |
| 30 | AMYLYX PHARMACEUTICALS INC | AMLX | 215,000 | $3.9M | 1.29% |
| 31 | CYMABAY THERAPEUTICS INC | 23257D103 | 237,900 | $3.5M | 1.17% |
| 32 | XENON PHARMACEUTICALS INC | XENE | 98,951 | $3.4M | 1.11% |
| 33 | IMMUNOVANT INC | IMVT | 85,000 | $3.3M | 1.07% |
| 34 | CRINETICS PHARMACEUTICALS IN | CRNX | 101,443 | $3.0M | 0.99% |
| 35 | SYNDAX PHARMACEUTICALS INC | SNDX | 200,000 | $2.9M | 0.96% |
| 36 | IMMUNOGEN INC | 45253H101 | 175,000 | $2.8M | 0.91% |
| 37 | STRUCTURE THERAPEUTICS INC | GPCR | 55,000 | $2.8M | 0.91% |
| 38 | AEROVATE THERAPEUTICS INC | 008064107 | 201,197 | $2.7M | 0.90% |
| 39 | MORPHOSYS AG | 617760202 | 400,000 | $2.7M | 0.88% |
| 40 | CYTOKINETICS INC | CYTK | 90,000 | $2.7M | 0.87% |
| 41 | MIRATI THERAPEUTICS INC | 60468T105 | 60,000 | $2.6M | 0.86% |
| 42 | EYEPOINT PHARMACEUTICALS INC | EYPT | 325,000 | $2.6M | 0.85% |
| 43 | VIKING THERAPEUTICS INC | VKTX | 225,000 | $2.5M | 0.82% |
| 44 | APELLIS PHARMACEUTICALS INC | APLS | 65,000 | $2.5M | 0.81% |
| 45 | ASTRIA THERAPEUTICS INC | 04635X102 | 300,000 | $2.2M | 0.74% |
| 46 | AMICUS THERAPEUTICS INC | FOLD | 175,000 | $2.1M | 0.70% |
| 47 | KARUNA THERAPEUTICS INC | 48576A100 | 12,500 | $2.1M | 0.70% |
| 48 | ACELYRIN INC | 00445A100 | 200,000 | $2.0M | 0.67% |
| 49 | ACELYRIN INC | 00445A100 | 200,000 | $2.0M | 0.67% |
| 50 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 100,000 | $2.0M | 0.66% |
| 51 | BRIDGEBIO PHARMA INC | BBIO | 75,000 | $2.0M | 0.65% |
| 52 | ACADIA PHARMACEUTICALS INC | ACAD | 80,000 | $1.7M | 0.55% |
| 53 | LEGEND BIOTECH CORP | LEGN | 22,500 | $1.5M | 0.50% |
| 54 | UNIQURE NV | QURE | 215,000 | $1.4M | 0.47% |
| 55 | ARCUS BIOSCIENCES INC | RCUS | 75,000 | $1.3M | 0.44% |
| 56 | TRAVERE THERAPEUTICS INC | TVTX | 150,000 | $1.3M | 0.44% |
| 57 | ARGENX SE | ARGX | 2,500 | $1.2M | 0.40% |
| 58 | VENTYX BIOSCIENCES INC | 92332V107 | 35,000 | $1.2M | 0.40% |
| 59 | AADI BIOSCIENCE INC | WHWK | 250,000 | $1.2M | 0.40% |
| 60 | KALVISTA PHARMACEUTICALS INC | KALV | 100,000 | $963,000 | 0.32% |
| 61 | BIOMEA FUSION INC | BMEA | 65,000 | $894,400 | 0.29% |
| 62 | ROIVANT SCIENCES LTD | ROIV | 64,000 | $747,520 | 0.25% |
| 63 | VERONA PHARMA PLC | 925050106 | 45,000 | $733,500 | 0.24% |
| 64 | INHIBRX INC | INBX | 35,000 | $642,250 | 0.21% |
| 65 | FUSION PHARMACEUTICALS INC | 36118A100 | 243,287 | $632,546 | 0.21% |
| 66 | ACUMEN PHARMACEUTICALS INC | ABOS | 150,000 | $622,500 | 0.20% |
| 67 | 89BIO INC | 282559103 | 30,000 | $463,200 | 0.15% |
| 68 | AVIDITY BIOSCIENCES INC | 05370A108 | 65,000 | $414,700 | 0.14% |
| 69 | RAIN ONCOLOGY INC | 75082Q105 | 325,000 | $280,085 | 0.09% |
| 70 | MERSANA THERAPEUTICS INC | 59045L106 | 61,250 | $77,788 | 0.03% |